Sobhan Pharmaceutical Group (DSOBHA) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- DSOBHA
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 |
|---|---|---|---|---|---|
| درآمد سود سهام | 5,296 | 59,399 | 54,545 | 94,623 | 35,446 |
| Total operating revenue | 5,296 | 59,399 | 54,545 | 94,623 | 35,446 |
| هزینه های حقوق، دستمزد و مزایا | -83,390 | -58,759 | -41,946 | -70,527 | -61,157 |
| Depreciation expense | -1,737 | -410 | -285 | - | - |
| Other expenses | -105,141 | -49,390 | -44,529 | 0 | 0 |
| جمع هزینه های عملیاتی | -190,268 | -108,559 | -90,780 | -70,527 | -61,157 |
| Operating profit (loss) | -184,972 | -49,160 | -36,235 | 24,096 | -25,711 |
| Finance costs | -152,523 | -184,216 | -130,902 | -109,392 | 0 |
| Other non-operating income and expenses | 171,241 | 76,555 | 277,169 | 701,653 | 858,951 |
| Profit (loss) from continuing operations before tax | -166,254 | -156,821 | 110,032 | 616,357 | 833,240 |
| Net profit (loss) from continuing operations | -166,254 | -156,821 | 110,032 | 616,357 | 833,240 |
| Net profit (loss) | -166,254 | -156,821 | 110,032 | 616,357 | 833,240 |
| Operating (rials) | -13 | -7 | -5 | 4 | -8 |
| Non-operating (rials) | 1 | -16 | 21 | 86 | 266 |
| Arising from continuing operations | -12 | -23 | 16 | - | - |
| سود (زیان) پایه هر سهم (ریال) | -12 rials | -23 rials | 16 rials | 90 rials | 258 rials |
| سود (زیان) خالص هر سهم (ریال) | -11 rials | -22 rials | 16 rials | 89 rials | 120 rials |
| Capital | 14,521,000 | 6,975,000 | 6,975,000 | 6,975,000 | 6,975,000 |
Reporting periods
37 periods are on file for this report, from the period ending 1388/06/31 to the period ending 1405/06/31.